US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 0.297
  • -0.001-0.44%
Close Mar 28 16:00 ET
  • 0.287
  • -0.010-3.24%
Post 20:01 ET
9.85MMarket Cap-0.11P/E (TTM)

Relmada Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-19.10%83.89M
-28.90%19.08M
1.39%23.01M
-27.69%18.82M
-18.35%22.99M
-35.69%103.7M
-30.68%26.83M
-41.42%22.69M
-42.81%26.03M
-26.49%28.15M
Selling and administrative expenses
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
-General and administrative expense
-22.86%37.72M
-33.13%8.08M
-3.10%11.86M
-34.09%8.1M
-21.23%9.68M
2.02%48.89M
2.06%12.08M
49.10%12.24M
-15.84%12.29M
-7.47%12.29M
Research and development costs
-15.75%46.18M
-25.43%11M
6.65%11.15M
-21.97%10.72M
-16.11%13.31M
-51.64%54.81M
-45.10%14.75M
-65.76%10.45M
-55.55%13.74M
-36.59%15.86M
Operating profit
19.10%-83.89M
28.90%-19.08M
-1.39%-23.01M
27.69%-18.82M
18.35%-22.99M
35.69%-103.7M
30.68%-26.83M
41.42%-22.69M
42.81%-26.03M
26.49%-28.15M
Net non-operating interest income expense
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
Non-operating interest income
-31.48%3.53M
-48.01%654.64K
-35.19%856.48K
-29.37%963.01K
-12.57%1.06M
93.72%5.15M
12.98%1.26M
59.67%1.32M
252.00%1.36M
266.01%1.21M
Other net income (expense)
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
-115.60%-241.16K
213.60%404.94K
58.20%-630.86K
-112.32%-639.63K
135.11%624.4K
Gain on sale of security
258.26%381.66K
-158.34%-236.22K
167.59%426.39K
113.70%87.65K
-83.37%103.85K
94.98%-241.16K
213.60%404.94K
58.20%-630.86K
44.95%-639.63K
135.11%624.4K
Income before tax
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Income tax
Net income
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Net income continuous Operations
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Minority interest income
Net income attributable to the parent company
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.04%-79.98M
25.86%-18.66M
1.25%-21.73M
29.78%-17.77M
17.07%-21.83M
37.09%-98.79M
33.68%-25.17M
44.18%-22M
36.64%-25.3M
33.78%-26.32M
Basic earnings per share
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
Diluted earnings per share
19.21%-2.65
25.30%-0.62
1.37%-0.72
29.76%-0.59
17.24%-0.72
38.11%-3.28
34.13%-0.83
44.27%-0.73
36.84%-0.84
37.86%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -19.10%83.89M-28.90%19.08M1.39%23.01M-27.69%18.82M-18.35%22.99M-35.69%103.7M-30.68%26.83M-41.42%22.69M-42.81%26.03M-26.49%28.15M
Selling and administrative expenses -22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M
-General and administrative expense -22.86%37.72M-33.13%8.08M-3.10%11.86M-34.09%8.1M-21.23%9.68M2.02%48.89M2.06%12.08M49.10%12.24M-15.84%12.29M-7.47%12.29M
Research and development costs -15.75%46.18M-25.43%11M6.65%11.15M-21.97%10.72M-16.11%13.31M-51.64%54.81M-45.10%14.75M-65.76%10.45M-55.55%13.74M-36.59%15.86M
Operating profit 19.10%-83.89M28.90%-19.08M-1.39%-23.01M27.69%-18.82M18.35%-22.99M35.69%-103.7M30.68%-26.83M41.42%-22.69M42.81%-26.03M26.49%-28.15M
Net non-operating interest income expense -31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M
Non-operating interest income -31.48%3.53M-48.01%654.64K-35.19%856.48K-29.37%963.01K-12.57%1.06M93.72%5.15M12.98%1.26M59.67%1.32M252.00%1.36M266.01%1.21M
Other net income (expense) 258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K-115.60%-241.16K213.60%404.94K58.20%-630.86K-112.32%-639.63K135.11%624.4K
Gain on sale of security 258.26%381.66K-158.34%-236.22K167.59%426.39K113.70%87.65K-83.37%103.85K94.98%-241.16K213.60%404.94K58.20%-630.86K44.95%-639.63K135.11%624.4K
Income before tax 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Income tax
Net income 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Net income continuous Operations 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Minority interest income
Net income attributable to the parent company 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.04%-79.98M25.86%-18.66M1.25%-21.73M29.78%-17.77M17.07%-21.83M37.09%-98.79M33.68%-25.17M44.18%-22M36.64%-25.3M33.78%-26.32M
Basic earnings per share 19.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.87
Diluted earnings per share 19.21%-2.6525.30%-0.621.37%-0.7229.76%-0.5917.24%-0.7238.11%-3.2834.13%-0.8344.27%-0.7336.84%-0.8437.86%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
8.950
eBay
EBAY
67.160
Collegium Pharmaceutical
COLL
29.710
4
Dorian LPG
LPG
22.500
5
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
12.325
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call